Kenya’s Pharmacy and Poisons Board has confirmed approval for the emergency use of Russia’s Sputnik V Covid-19 vaccine in Kenya after tests.
The Poisons board gave the emergency use authorization to AstraZeneca vaccine and the Sputnik V vaccine after a successful evaluation process.
“This is not a registration. The application for Emergency Use Authorization of Russia’s Sputnik V vaccine has been approved after it met all requirements,” the board said.
In a notice on Wednesday, the board said in reviewing the Sputnik V vaccine, it considered all aspects of quality, safety and efficacy.
“It is wholesomely safe. The Board continues to review the safety of all authorized products in the market,” it said.
The poisons board is to authorise and safely monitor medicines and health technologies.
Sputnik V is a Covid-19 vaccine developed by Russia’s Gamaleya National Centre of Epidemiology and Microbiology.